Notice: This company has been marked as potentially delisted and may not be actively trading. Lianluo Smart (LLIT) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesTrends LLIT vs. SNOA, STSS, AMIX, BJDX, VERO, AFIB, NAYA, AVGR, INVO, and DYNTShould you be buying Lianluo Smart stock or one of its competitors? The main competitors of Lianluo Smart include Sonoma Pharmaceuticals (SNOA), Sharps Technology (STSS), Autonomix Medical (AMIX), Bluejay Diagnostics (BJDX), Venus Concept (VERO), Acutus Medical (AFIB), NAYA Biosciences (NAYA), Avinger (AVGR), INVO Bioscience (INVO), and Dynatronics (DYNT). These companies are all part of the "medical" sector. Lianluo Smart vs. Sonoma Pharmaceuticals Sharps Technology Autonomix Medical Bluejay Diagnostics Venus Concept Acutus Medical NAYA Biosciences Avinger INVO Bioscience Dynatronics Lianluo Smart (NASDAQ:LLIT) and Sonoma Pharmaceuticals (NASDAQ:SNOA) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, valuation, dividends, profitability, risk, earnings, analyst recommendations, institutional ownership and community ranking. Does the media refer more to LLIT or SNOA? In the previous week, Sonoma Pharmaceuticals had 2 more articles in the media than Lianluo Smart. MarketBeat recorded 2 mentions for Sonoma Pharmaceuticals and 0 mentions for Lianluo Smart. Sonoma Pharmaceuticals' average media sentiment score of 1.43 beat Lianluo Smart's score of 0.00 indicating that Sonoma Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Lianluo Smart Neutral Sonoma Pharmaceuticals Positive Does the MarketBeat Community prefer LLIT or SNOA? Sonoma Pharmaceuticals received 112 more outperform votes than Lianluo Smart when rated by MarketBeat users. However, 70.27% of users gave Lianluo Smart an outperform vote while only 67.50% of users gave Sonoma Pharmaceuticals an outperform vote. CompanyUnderperformOutperformLianluo SmartOutperform Votes10470.27% Underperform Votes4429.73% Sonoma PharmaceuticalsOutperform Votes21667.50% Underperform Votes10432.50% Do insiders and institutionals have more ownership in LLIT or SNOA? 28.8% of Lianluo Smart shares are held by institutional investors. Comparatively, 2.0% of Sonoma Pharmaceuticals shares are held by institutional investors. 22.9% of Lianluo Smart shares are held by company insiders. Comparatively, 3.9% of Sonoma Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more risk & volatility, LLIT or SNOA? Lianluo Smart has a beta of 0.16, suggesting that its share price is 84% less volatile than the S&P 500. Comparatively, Sonoma Pharmaceuticals has a beta of 1.41, suggesting that its share price is 41% more volatile than the S&P 500. Which has higher valuation & earnings, LLIT or SNOA? Lianluo Smart has higher earnings, but lower revenue than Sonoma Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLianluo Smart$380K2.44-$4.45MN/AN/ASonoma Pharmaceuticals$12.73M0.28-$4.84M-$4.99-0.53 Is LLIT or SNOA more profitable? Lianluo Smart has a net margin of 0.00% compared to Sonoma Pharmaceuticals' net margin of -27.21%. Lianluo Smart's return on equity of 0.00% beat Sonoma Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Lianluo SmartN/A N/A N/A Sonoma Pharmaceuticals -27.21%-59.58%-24.33% SummaryLianluo Smart beats Sonoma Pharmaceuticals on 8 of the 13 factors compared between the two stocks. Get Lianluo Smart News Delivered to You Automatically Sign up to receive the latest news and ratings for LLIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LLIT vs. The Competition Export to ExcelMetricLianluo SmartSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$927,000.00$4.88B$5.61B$9.14BDividend YieldN/A52.56%5.36%3.98%P/E RatioN/A26.4289.6917.66Price / Sales2.4453.761,219.4081.09Price / CashN/A52.0644.3437.71Price / Book-0.718.245.134.73Net Income-$4.45M$13.79M$118.85M$225.42M Lianluo Smart Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LLITLianluo SmartN/A$0.42-4.3%N/A-48.5%$927,000.00$380,000.000.006Gap UpSNOASonoma Pharmaceuticals1.8966 of 5 stars$2.64-7.0%N/A+1,530.3%$3.54M$12.73M-0.53180Short Interest ↓Positive NewsSTSSSharps Technology1.5172 of 5 stars$1.46-11.5%N/AN/A$3.38MN/A-0.183News CoverageAMIXAutonomix Medical3.1248 of 5 stars$2.93-5.2%$28.00+855.6%N/A$3.37MN/A-0.181Short Interest ↓Gap DownBJDXBluejay Diagnostics0.638 of 5 stars$3.93-11.5%N/A-98.7%$2.45M$250,000.000.009Short Interest ↓Gap DownVEROVenus Concept2.9505 of 5 stars$0.33-6.6%N/A-69.6%$2.38M$76.35M-0.04410Short Interest ↓AFIBAcutus MedicalN/A$0.07+21.2%N/A-79.4%$2.08M$7.16M0.00340Gap DownNAYANAYA BiosciencesN/A$0.46-4.2%$2.00+334.7%N/A$2.06M$3.02M0.00N/APositive NewsAVGRAvinger2.9594 of 5 stars$0.57-3.0%$5.00+774.9%-81.6%$1.89M$7.65M-0.0570Analyst ForecastShort Interest ↓Gap DownINVOINVO BioscienceN/A$0.48+2.6%N/A-55.7%$1.83M$5.77M0.0025Gap UpDYNTDynatronicsN/A$0.18flatN/A-75.0%$1.59M$33.60M-0.19200Upcoming EarningsAnalyst Forecast Related Companies and Tools Related Companies Sonoma Pharmaceuticals Competitors Sharps Technology Competitors Autonomix Medical Competitors Bluejay Diagnostics Competitors Venus Concept Competitors Acutus Medical Competitors NAYA Biosciences Competitors Avinger Competitors INVO Bioscience Competitors Dynatronics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LLIT) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredTrump’s back in the oval office. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. And he says 2025 could be...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lianluo Smart Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Lianluo Smart With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
